Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS
- 9 May 2000
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 54 (9) , 1859-1861
- https://doi.org/10.1212/wnl.54.9.1859
Abstract
Article abstract The association of the human leukocyte antigen (HLA)-DR2 allele with brain MRI signal abnormalities and with the development of MS was assessed in 178 patients enrolled in the Optic Neuritis Treatment Trial. HLA haplotype DR2 was present in 85 (48%) of the 178 patients. Its presence was associated with increased odds of probable or definite MS at 5 years (odds ratio, 1.92; 95% confidence interval, 1.01 to 3.67; p = 0.04). The association was most apparent among patients with signal abnormalities on baseline brain MRI.Keywords
This publication has 10 references indexed in Scilit:
- Identification of autoantibodies associated with myelin damage in multiple sclerosisNature Medicine, 1999
- Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics GroupHuman Molecular Genetics, 1998
- Optic neuritisNeurology, 1998
- Primary progressive multiple sclerosisBrain, 1997
- Western versus asian types of multiple sclerosis: Immunogenetically and clinically distinct disordersAnnals of Neurology, 1996
- Genetics of Demyelinating DiseasesBrain Pathology, 1996
- Patterns of oligodendroglia pathology in multiple sclerosisBrain, 1994
- Brain Magnetic Resonance Imaging in Acute Optic NeuritisArchives of Neurology, 1993
- Design, methods, and conduct of the optic neuritis treatment trialControlled Clinical Trials, 1993
- Different HLA DR2‐DQw1 haplotypes in Sardinian and northern Italian populations: Implications for multiple sclerosis susceptibilityTissue Antigens, 1991